Lipigon Pharmaceuticals AB
STO:LPGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lipigon Pharmaceuticals AB
STO:LPGO
|
SE |
|
A
|
Aesthetic Medical International Holdings Group Ltd
OTC:PAIYY
|
CN |
|
Xlife Sciences AG
F:XLS
|
CH |
|
Piala Inc
TSE:7044
|
JP |
|
D
|
d'Amico International Shipping SA
XBER:B7C
|
LU |
|
O
|
Ora Gold Ltd
XMUN:TJ3
|
AU |
Shareholder Yield
Current shareholder yield for LPGO is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LPGO Price
Lipigon Pharmaceuticals AB
| Average Annual Return | -53.71% |
| Standard Deviation of Annual Returns | 30.07% |
| Max Drawdown | -100% |
| Market Capitalization | 908.9k SEK |
| Shares Outstanding | 605 930 000 |
| Percentage of Shares Shorted |
N/A
|
